Letter by Janket et al regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction" [2]

Circulation

Volumn 116, Issue 6, 2007, Pages

  Janket, Sok Ja ^a   Shen, Ye ^b   Meurman, Jukka H ^c  

^a BOSTON UNIVERSITY   (United States)

^b YALE UNIVERSITY   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DISEASE MARKER; HEART DISEASE; LETTER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCIENTIFIC LITERATURE; VACCINATION; HUMAN; NOTE; PREDICTION AND FORECASTING; ROC CURVE; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 34548168899     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.714360     Document Type: Letter

References (6)

1. Cook N. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928-935.
2. Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? BMJ. 1999;319:1562-1565.
3. Levinson S, Elin R. What is C-reactive protein telling us about coronary artery disease? Arch Intern Med. 2002;162:389-392.
4. Libby P, Ridker, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-43.
5. Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify? Am J Med. 2006;119:166.e17-166.e28.
6. Greenland P, O'Malley PG. When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk [comment]. Arch Intern Med. 2005;165:2454-2456.